Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
December’s full moon is the last supermoon of the year. Here’s what to know - 2The 25 Most Notable Style Crossroads in History
- 3German finance minister sees advantages of smartphones in schools
- 4Space station changes command, setting stage for Crew 11 departure
- 5The most effective method to Plan an Incineration Administration: A Bit by bit Guide.
- Artemis II astronauts arrive in Florida to prepare for launch to the moon
- Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
- 10 Demonstrated Tips to Boost Your New Android Cell phone: A Thorough Aide
- The Most Compelling Innovation Advancements Somewhat recently
- Ocean side Locations for a Family Excursion
- 'We were genuinely astonished': This moss survived 9 months outside the International Space Station and could still grow on Earth
- Toddler diagnosed with cancer makes remarkable recovery after aggressive treatment
- The Best Traditional Music Arrangers in History
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
